Vivos Therapeutics, Inc. VVOS
NASDAQ · United States · Health Technology
$0.1520+0.00 (+2.01%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-14 | -0.31 | -0.41 | +24.4% | $5.15M | -8.5% | -1.3%$0.31→$0.30 |
| Q1 2026 | 2026-05-20 | -0.52 | -0.45 | -15.6% | — | — | 0.0%$0.58→$0.58 |
| Q4 2025 | 2026-04-15 | -0.58 | -0.48 | -20.8% | — | — | -19.3%$1.35→$1.09 |
| Q3 2025 | 2025-11-19 | -0.49 | -0.51 | +3.9% | — | — | -14.2%$2.47→$2.12 |
| Q2 2025 | 2025-08-19 | -0.55 | -0.38 | -44.7% | — | — | — |
| Q1 2025 | 2025-05-15 | -0.45 | -0.40 | -12.5% | — | — | — |
| Q4 2024 | 2025-03-31 | -0.28 | -0.43 | +34.9% | — | — | — |
| Q3 2024 | 2024-11-14 | -0.40 | -0.70 | +42.9% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.